Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)
- PMID: 28342178
- PMCID: PMC6230477
- DOI: 10.1002/dta.2196
Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)
Abstract
The psychoactive properties of lysergic acid diethylamide (LSD) have fascinated scientists across disciplines and the exploration of other analogues and derivatives has been motivated by deepening the understanding of ligand-receptor interactions at the molecular level as well as by the search for new therapeutics. Several LSD congeners have appeared on the new psychoactive substances (NPS) market in the form of blotters or powders. Examples include 1-propionyl-LSD (1P-LSD), AL-LAD, and LSZ. The absence of analytical data for novel compounds is a frequent challenge encountered in clinical and toxicological investigations. Two newly emerging lysergamides, namely N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1P-ETH-LAD, were characterized by gas chromatography-mass spectrometry (GC-MS), low and high mass accuracy electrospray MS(/MS), GC solid-state infrared analysis, high performance liquid chromatography diode array detection as well as nuclear magnetic resonance spectroscopy. Limited analytical data for ETH-LAD were previously available, whereas information about 1P-ETH-LAD has not previously been encountered in the scientific literature. This study extends the characterization of lysergamides distributed on the NPS market, which will help to make analytical data available to clinicians, toxicologists, and other stakeholders who are likely to encounter these substances. The analysis of a test incubation of 1P-ETH-LAD with human serum at 37°C by LC single quadrupole MS at various time points (0-6 h, once per hour and one measurement after 24 h) revealed the formation of ETH-LAD, suggesting that 1P-ETH-LAD might serve as a pro-drug. 1P-ETH-LAD was still detectable in serum after 24 h. Copyright © 2017 John Wiley & Sons, Ltd.
Keywords: LSD; chemical analysis; lysergamides; new psychoactive substances; psychedelics.
Copyright © 2017 John Wiley & Sons, Ltd.
Figures





Similar articles
-
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).Drug Test Anal. 2017 Jan;9(1):38-50. doi: 10.1002/dta.1985. Epub 2016 Jun 6. Drug Test Anal. 2017. PMID: 27265891 Free PMC article.
-
In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.Anal Bioanal Chem. 2019 Jul;411(19):4751-4763. doi: 10.1007/s00216-018-1558-9. Epub 2019 Jan 7. Anal Bioanal Chem. 2019. PMID: 30617391
-
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).Drug Test Anal. 2019 Aug;11(8):1122-1133. doi: 10.1002/dta.2613. Epub 2019 Jun 18. Drug Test Anal. 2019. PMID: 31083768 Free PMC article.
-
Determination of lysergide (LSD) and phencyclidine in biosamples.J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):189-200. doi: 10.1016/s0378-4347(97)00538-0. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9700559 Review.
-
Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.J Pharm Biomed Anal. 2014 Jan;87:176-90. doi: 10.1016/j.jpba.2013.04.037. Epub 2013 May 6. J Pharm Biomed Anal. 2014. PMID: 23721687 Review.
Cited by
-
Clinical Research on Lysergic Acid Diethylamide (LSD) in Psychiatry and Neuroscience.Pharmaceuticals (Basel). 2025 Mar 29;18(4):499. doi: 10.3390/ph18040499. Pharmaceuticals (Basel). 2025. PMID: 40283936 Free PMC article. Review.
-
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug Test Anal. 2022 Aug;14(8):1503-1518. doi: 10.1002/dta.3281. Epub 2022 May 29. Drug Test Anal. 2022. PMID: 35524430 Free PMC article.
-
Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.Molecules. 2024 Dec 4;29(23):5717. doi: 10.3390/molecules29235717. Molecules. 2024. PMID: 39683876 Free PMC article.
-
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).Drug Test Anal. 2020 Jun;12(6):812-826. doi: 10.1002/dta.2789. Epub 2020 Apr 20. Drug Test Anal. 2020. PMID: 32180350 Free PMC article.
-
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).Psychopharmacology (Berl). 2019 Feb;236(2):799-808. doi: 10.1007/s00213-018-5055-9. Epub 2018 Oct 8. Psychopharmacology (Berl). 2019. PMID: 30298278 Free PMC article.
References
-
- Schultes RE. Hallucinogens of plant origin. Science. 1969;163:245. - PubMed
-
- Stoll A, Hofmann A. Partialsynthese von Alkaloiden vom Typus des Ergobasins. 6. Mitteilung über Mutterkornalkaloide. Helv. Chim. Acta. 1943;26:944.
-
- Stoll WA. Lysergsäure-diäthylamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz. Arch. Neurol. Psychiatr. 1947;60:279.
-
- Hoffman AJ, Nichols DE. Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives. J. Med. Chem. 1985;28:1252. - PubMed
-
- Nichols DE, Oberlender R, McKenna DJ. In: Biochemistry and Physiology of Substance Abuse. Watson RR, editor. Vol. 3. CRC Press; Boca Raton, FL, USA: 1991. p. 1.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous